Navigation Links
Paul D. Duke Resigns From Mesa's Board of Directors
Date:7/8/2010

LAKEWOOD, Colo., July 8 /PRNewswire-FirstCall/ -- Mesa Laboratories, Inc. (Nasdaq: MLAB) today announced that Paul D. Duke, citing health reasons, has resigned as a member of the Company's Board of Directors, effectively immediately.

"Paul's experience and insight have been extremely helpful to me and the whole management team at Mesa," said John J. Sullivan, President and CEO.  "Paul managed Mesa's Medical product line from its infancy until 2002 when he retired from the Company as an active employee.  Mesa's position as a key quality control supplier to the worldwide dialysis industry is largely due to the effort that Paul put into building the Medical product line and Mesa's brand in the marketplace.  I would like to thank Paul for his many years of service, not only to Mesa, but to the whole dialysis industry."

"Paul has been a key part of Mesa's success since cofounding the company with me in 1982," said Luke R. Schmieder, Chairman.  "Paul was a trusted colleague and friend who helped build Mesa into the company it is today.  Though he leaves as a member of our Board, Paul will always have a special place in the history of Mesa."

Mesa Laboratories develops, acquires, manufactures and markets electronic instruments and disposables for industrial, pharmaceutical and medical applications.

This news release contains forward-looking statements which involve risks and uncertainties.  The Company's actual results could differ materially from those in any such forward-looking statements.  Additional information concerning important factors that could cause results to differ materially from those in any such forward-looking statement is contained in the Company's Annual Report on Form-10K for the year ended March 31, 2010 as filed with the Securities and Exchange Commission, and from time to time in the Company's other reports on file with the Commission.


'/>"/>
SOURCE Mesa Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. InteRNA Technologies Announces Establishment of Scientific Advisory Board
2. Mitchell J. Blutt, M.D. Appointed to Questcor Board of Directors
3. NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board
4. Vanda Pharmaceuticals Adds Former U.S. Surgeon General, Steven Galson, to its Board of Directors
5. Accuray Appoints Peter Fine to Board of Directors
6. K-V Pharmaceutical Company Announces the Nomination and Appointment of New Independent Member to the Board of Directors
7. HealthWarehouse.com Receives VIPPS Accreditation From The National Association of Boards of Pharmacy
8. DUSA Pharmaceuticals Announces Slate of Nominees for Election to the Board of Directors
9. Young Innovations, Inc. Board of Directors Declares Quarterly Dividend and Announces Election of New Officer
10. Axelars Board Strengthened
11. Gelesis Unveils Novel Non-Invasive Capsulated Device for Obesity and Presents Clinical Data; Appoints Former Pfizer R&D President to Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , December 5, 2016 PharmaBoardroom today releases ... . ... This report offers companies, investors, policymakers, and stakeholders crucial insight ... of Europe , home to some of the world,s ... pharmaceutical companies in Novartis and Roche, and with a number one ranking ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. 5, 2016 ... treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete ... better safety and tolerability profile of ropeginterferon alfa-2b versus HU ... and the ongoing long-term follow-up trial CONTINUATION-PV to obtain European ... intends to present this data to the FDA as it ...
(Date:12/4/2016)... Attorney General of Louisiana , Charles ... firm of Kahn Swick & Foti, LLC ("KSF"), announces that ... LCI ). On November 3, ... in Generic-Drug Probe to Be Filed by Year-End," which reported ... two years ago, now spans more than a dozen companies," ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... December 05, 2016 , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi ... patients who do not do their research and undergo cosmetic dermatology treatments from unqualified ... midst of a renaissance and every other month a new treatment or device is ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... CardioQuick Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with ... , Over the last 60 years, studies have shown that single electrode ...
(Date:12/4/2016)... ... ... James Earl Jones is known for myriad roles on stage and screen, he has ... the forthcoming episodes examines mammogram techniques; a very important part of preventative medicine. , ... detection. Like any other disease, treatments have a much higher chance of success if ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to gain ... of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser Resurfacing ... age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or textural ...
(Date:12/2/2016)... ... 02, 2016 , ... Lori G. Cohen and Sara K. ... at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference , ... of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health ...
Breaking Medicine News(10 mins):